Wednesday, September 2, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 15.5
The tape looks choppy and rotational rather than broadly bullish: mega-cap tech and many industrials/consumer names are down 5-20% over the past month while a clear rotation into energy (refiners and E&Ps), agricultural chemicals, and select healthcare/pharma names is pushing those groups to or near 52-week highs on sustained 5-day and 30-day gains. The most credible near-term setups sit in these strength pockets rather than in broadly oversold names.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | RVTY | SKIP | — | $129.79 → $137.24 stop $119.66 |
Position cap reached — 103 of 20 slots in use. |
| #2 | MCK | SKIP | — | $920.80 → $969.71 stop $856.34 |
Position cap reached — 103 of 20 slots in use. |
| #3 | CTVA | SKIP | — | $90.05 → $95.12 stop $83.75 |
Position cap reached — 103 of 20 slots in use. |
| #4 | SLB | SKIP | — | $57.99 → $61.10 stop $53.06 |
Position cap reached — 103 of 20 slots in use. |
| #5 | ADM | SKIP | — | $85.45 → $90.36 stop $78.53 |
Position cap reached — 103 of 20 slots in use. |
Already open: AMP (to Sep 3), RJF (to Sep 4), NVDA (to Sep 5), SWK (to Sep 6), WAT (to Sep 9), LLY (to Sep 10), DRI (to Sep 11), DXCM (to Sep 11), BDX (to Sep 12), BLK (to Sep 12), EXPD (to Sep 13), FDX (to Sep 13) … and 91 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Revvity provides life-sciences tools and diagnostic technology used in healthcare research and testing. Its stock has climbed steadily for a month and remains solidly ahead of the market, though the pace of gains has slowed slightly in the last week. The main risk is that healthcare-technology stocks can see sharp swings, and the recent slowdown in short-term momentum bears watching.
Why the AI likes it
What could go wrong
Calibrated probability: 66% (raw model estimate: 69%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
McKesson is one of the largest distributors of pharmaceuticals and medical supplies in the country. Its shares have risen steadily and are outperforming the market, though the stock's longer-term trend indicator hasn't fully confirmed an uptrend yet. The main risk is meaningful recent stock selling by the CEO, alongside the general chance of a pullback after a strong run.
Why the AI likes it
What could go wrong
Calibrated probability: 66% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Corteva sells seeds and crop-protection chemicals to farmers worldwide. The company just beat earnings expectations and raised its full-year profit guidance, telling investors it has 'confidence in the opportunities ahead' — a strong, recent vote of confidence from management, and it's also in the middle of splitting into two separate public companies this fall, which could unlock further value. The main risk is that the stock has already rallied nearly 19% in the past month, so some of this good news may already be reflected in the price.
Why the AI likes it
What could go wrong
Calibrated probability: 66% (raw model estimate: 68%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
SLB (formerly Schlumberger) provides equipment and services to oil and gas drilling companies around the world. Its stock has surged over the last month and even accelerated in the past week, benefiting from strength across the energy sector. The main risks are that the CEO has been selling shares recently and that energy stocks can swing quickly with oil prices.
Why the AI likes it
What could go wrong
Calibrated probability: 66% (raw model estimate: 63%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Archer-Daniels-Midland processes and trades crops like corn and soybeans into food, feed, and industrial products. The stock has been steadily climbing and is comfortably ahead of the broader market, supported by strength across agricultural names. The main risk is a reversal if crop prices or agricultural demand weaken.
Why the AI likes it
What could go wrong
Calibrated probability: 66% (raw model estimate: 68%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by October 2, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 503 S&P 500 constituents and short-listed 24 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.